Invitae Acquires Diploid, Maker Of AI Engine To Enable Clinical Diagnosis Using Whole Genome Sequencing In Minutes

Industry: , ,    2020-03-11

* INVITAE ACQUIRES DIPLOID, MAKER OF ARTIFICIAL-INTELLIGENCE ENGINE TO ENABLE CLINICAL DIAGNOSIS USING WHOLE GENOME SEQUENCING IN MINUTES

* INVITAE CORP – WILL ACQUIRE DIPLOID FOR APPROXIMATELY $95 MILLION

* INVITAE CORP – ACQUISITION HAS CLOSED

* INVITAE CORP – ACQUISITION PRICE OF ABOUT $95 MILLION, CONSISTS OF $32 MILLION IN CASH & $63 MILLION IN INVITAE COMMON STOCK

print
Source: